The New Zelnorm-al (Part 2): More Thoughts On The Revival Of The 5HT4 Class

Looming return of Zelnorm to US market is milestone event for current regulatory climate. But FDA’s hands-on work to resurrect a different 5HT4 agonist, prucalopride, probably says more about what is truly different about the agency today.